Stroke Circulatory System Stroke, not specified as haemorrhage or infarction
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Stroke patients were diagnosed according to criteria of cerebral arterial thrombosis in Western medicine and the criteria of apoplexy in Chinese medicine 2. Stroke occurred within 14 days 3. Male or female, aged 40-75 4. National Institute of Health Stroke Scale (NIHSS) grade from 4 to 21 5. The muscle strength of the affected limbs is less than grade 3 6. No disorder of consciousness according to Glasgow Coma Scale (GCS) 7. Patients suffering their first attack or with a cerebral stroke history but with on serious deformity, modified Rankin SCale (mRS) grade >1 8. Diagnosed by the computed tomography (CT) or magnetic resonance imaging (MRI) 9. Patients who took part in the trial voluntarily and signed the informed consent form
Exclusion criteria
Exclusion criteria: 1. Patients receiving treatment for thrombolysis 2. Patients also have other neurological diseases or other illness which may cause abnormal muscle tension 3. Patients involved in other clinical trials, or having undergone other clinical trials in the last 3 months 4. Patients with severe primary diseases of the cardiovascular system, liver, kidney, hematopoietic system, or psychopathy 5. Pregnant women or women who are breastfeeding 6. Congenital disabilities
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Modified Ashworth Scale for Spasticity (MASS) 2. Fugl-Meyer (FMA) 3. Motor assessment scale (MAS) Assessments will be conducted at baseline and at week 2, 4 and 12 follow-up. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Activities of daily living (ADL) 2. The NIH Stroke Scale (NIHSS) 3. Stroke Speciality-Quality of Life (SS-QOL) 4. Modified Rankin Scale (mRS) Assessments will be conducted at baseline and at week 2, 4 and 12 follow-up, it is likely to adopt the follow up face to face. | — |
Countries
China